Know Cancer

or
forgot password

Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy


N/A
18 Years
N/A
Open (Enrolling)
Both
Cancer Survivor, Breast Cancer, Colorectal Cancer, Gynecological Cancer, Ovarian Cancer, Uterine Cancer

Thank you

Trial Information

Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy


MBCR is a step wise standardized behavioral intervention of MBSR. The program is usually
conducted in eight weekly class sessions that are 2-2.5 hours in length. During class
sessions, participants are presented with mindfulness meditation techniques and share their
experiences related to these meditation practices. There is a home practice component with
an expectation of regular home meditation practice of 45 minutes per day. In addition to
home meditation practice there are often reading assignments and reflective exercises that
relate to mindfulness. A full day retreat generally occurs in the second half of the course,
providing an opportunity for class participants to gain extended experience with mindfulness
techniques.


Inclusion Criteria:



- Stage I-III breast cancer, gynecologic cancer or colorectal cancer

- Cancer survivor at least 18 years of age at the time of study enrollment

- Completed chemotherapy within the past six months at the time of consent (adjuvant
hormone therapy is allowed)

Exclusion Criteria:

- Psychologic disease in which informed consent cannot be obtained from the subject

- Need for ongoing chemotherapy and/or radiation therapy

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

Change in Medical Outcomes Study Scores - Intervention versus Control

Outcome Description:

MOS SF-36: Medical Outcomes Study 36-Item Short-Form

Outcome Time Frame:

Day 1, Week 8 and 4 Month Follow-Up

Safety Issue:

No

Principal Investigator

Anne Blaes, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Masonic Cancer Center, University of Minnesota

Authority:

United States: Institutional Review Board

Study ID:

2012NTLS014

NCT ID:

NCT01601548

Start Date:

July 2012

Completion Date:

July 2013

Related Keywords:

  • Cancer Survivor
  • Breast Cancer
  • Colorectal Cancer
  • Gynecological Cancer
  • Ovarian Cancer
  • Uterine Cancer
  • Breast Neoplasms
  • Colorectal Neoplasms
  • Ovarian Neoplasms
  • Uterine Neoplasms

Name

Location
Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota  55455